Search

everythinglearnresearchcommunity

for

Search:↓

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Managing PCOS is hard because it varies a lot, treatments are limited, and there's a lot of false information online.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

A new PAX9 gene mutation causes missing teeth and hair problems, but not skin or nail issues.

Early-stage skin cells help regenerate hair follicles, with proteins SDF1, MMP3, biglycan, and LTBP1 playing key roles.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Non-ablative fractional laser treatments have a low risk of side effects in Asian patients.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Linoleic acid from Malva verticillata seeds may help treat hair loss by promoting hair cell growth and blocking baldness signals.

Researchers used CRISPR/Cas9 to create a goat with a gene that increased cashmere production by 74.5% without affecting quality.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

Two Sikh brothers developed permanent hair loss from wearing turbans tightly, a condition that became apparent after they moved to Austria.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

Alopecia greatly lowers the quality of life for South African Black women, especially affecting their self-image and social interactions.

Reducing copper (II) ion levels in hair can decrease hair damage.

A woman with severe angioedema improved significantly after treatment with rituximab.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.